Table 2. Baseline characteristics of patients with HCV Genotype 2 who started treatment with PegIFN/RBV.

Parameter*	Value	Range	n =
Male [%]	63.4		n = 102/161
Age [years]	49.8±12.0	26.4–79.2	n = 160
Weight [kg]	78.0±16.4	47.0–149.0	n = 160
BMI [kg/m2]	26.1±4.9	16.7–45.0	n = 158
CoO Germany [%]	53.1		n = 85
CoO EE/USSR [%]	34.4		n = 55
CoO Mediterranen [%]	8.8		n = 14
CoO Others [%]	3.8		n = 6
HCV RNA [log10 IU/mL]	6.2±1.1	2.7–8.2	n = 154
ALT [U/L]	68.0±93.0	14.0–542.0	n = 152
Cirrhosis [%]	5.6		n = 9/161
Steatosis [%]	29.3		n = 41/140